Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2003-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes
NCT00869414
Insulin Glargine Versus Twice-Daily NPH
NCT00687453
Insulin Glargine in Type 1 Diabetes Mellitus
NCT00272090
A Study in Adults With Type 1 Diabetes
NCT01421147
Insulin Glargine at Bedtime or in AM Versus NPH
NCT00686712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
With late night snack
At 10 p.m. a late night snack (one slice of whole meal rye bread containing approximately 20 g of carbohydrate) was eaten from Type 1 diabetic patients on an intensified conventional treatment regimen.
Late night snack
The late night snack was one slice of whole meal rye bread containing approximately 20 g of carbohydrate.
Without late night snack
Not nutrients (No late night snack) were consumed at 10 p.m. from Type 1 diabetic patients on an intensified conventional treatment regimen..
No late night snack
Patient consumed no nutrients at late night.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Late night snack
The late night snack was one slice of whole meal rye bread containing approximately 20 g of carbohydrate.
No late night snack
Patient consumed no nutrients at late night.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Basal insulin substitution with insulin glargine at least 3 month
Exclusion Criteria
* Severe and clinical significant gastroparesis
* History of pancreatitis or pancreatic cancer
* Severe Liver disorder (liver enzymes \> three times upper normal limit)
* Pregnancy
* Drug- or alcohol abuse
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Diabeteszentrum Bad Lauterberg im Harz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael A. Nauck
Prof. Dr. med. Michael A. Nauck
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael A. Nauck, Prof.
Role: PRINCIPAL_INVESTIGATOR
St. Josef-Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Diabeteszentrum Bad Lauterberg
Bad Lauterberg im Harz, Lower Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Late night snack & Lantus
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.